S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Petros Pharmaceuticals (PTPI) Earnings Date, Estimates & Call Transcripts

$1.65
-0.01 (-0.60%)
(As of 02/23/2024 ET)

Earnings Summary

Latest
Earnings Date
Nov. 15Estimated
Actual EPS
(Nov. 15)
-$2.31 Missed By -$2.31
Skip Charts & View Estimated and Actual Earnings Data

PTPI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PTPI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PTPI Earnings Date and Information

Petros Pharmaceuticals last posted its quarterly earnings data on November 15th, 2023. The reported ($2.31) earnings per share for the quarter. The business earned $1.68 million during the quarter. Petros Pharmaceuticals has generated $0.00 earnings per share over the last year.

Petros Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/15/2023Q3 2023-($2.31)($2.31)($2.31)-$1.68 million
8/14/2023Q2 2023-($1.20)($1.20)($1.20)-$1.99 million
5/15/2023Q1 2023-($0.66)($0.66)($0.66)-$2.52 million
11/15/2022Q3 2022-($67.00)($67.00)($6.70)-($1.46) million
8/15/2022Q2 2022-($0.90)($0.90)($0.09)-$4.19 million
5/16/2022Q1 2022-($0.10)($0.10)($0.01)-$2.47 million
4/1/2022Q4 2021-($7.20)($7.20)($0.69)-($0.87) million
11/15/2021Q3 2021-($1.70)($1.70)($0.17)-$2.15 million
8/17/2021Q2 2021-($4.50)($4.50)($0.68)-$2.46 million
5/17/2021Q1 2021-($2.40)($2.40)($0.79)-$4.08 million












Petros Pharmaceuticals Earnings - Frequently Asked Questions

When did Petros Pharmaceuticals announce their last quarterly earnings?

Petros Pharmaceuticals (NASDAQ:PTPI) last announced its quarterly earning data on Wednesday, November 15, 2023. Learn more on PTPI's earnings history.

How much revenue does Petros Pharmaceuticals generate each year?

Petros Pharmaceuticals (NASDAQ:PTPI) has a recorded annual revenue of $5.99 million.

How much profit does Petros Pharmaceuticals generate each year?

Petros Pharmaceuticals (NASDAQ:PTPI) has a recorded net income of -$20.04 million. PTPI has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:PTPI) was last updated on 2/23/2024 by MarketBeat.com Staff